Symptoms of Fibromyalgia Syndrome have Effects on Pain Grade

Abstract

Objective

To define different pain grades in individuals with fibromyalgia syndrome (FMS) and investigate the effects of pain degree on disease impact, kinesiophobia, pain-related concerns and quality of life.

Materials and methods

This cross-sectional and descriptive study was conducted with a total of 93 female individuals with FMS. The individuals with FMS were grouped according to different pain grades using the Graded Chronic Pain Scale. Clinical impact was assessed among these groups in terms of the following outcome measures: disease impact, kinesiophobia, pain-related concerns and quality of life.

Results

Of the individuals with FMS, 30 were included in the mild pain group, 13 in the bothersome pain group, and 50 in the high-impact pain group. There were significant differences between these three groups in terms of disease impact (p<0.001), kinesiophobia (p<0.001), pain-related concerns (p=0.017), the physical component of quality of life (p=0.007)and the mental component of quality of life (p<0.001). Disease impact, kinesiophobia and pain-related concern levels were higher in the high-impact pain group than in the mild and bothersome pain groups. The physical and mental component score of quality of life was lower in the high-impact pain group than in the mild group.

Conclusions

Individuals with FMS with different pain grades differ in terms of disease impact, kinesiophobia levels, pain-related concerns and quality of life levels. The differentiation of pain grades may be important for the evaluation process and specific treatment planning.

Zusammenfassung

Hintergrund und Ziel

Ziel der vorliegenden Studie war es, verschiedene Schmerzgrade bei Personen mit Fibromyalgie-Syndrom (FMS) zu definieren und den Einfluss des Schmerzgrades auf Krankheitsauswirkungen, Kinesiophobie, schmerzbedingte Probleme und Lebensqualität zu untersuchen.

Material und Methode

Insgesamt wurden 93 Patientinnen mit FMS in die deskriptive Querschnittstudie aufgenommen. Mithilfe der Skala GCPS (Graded Chronic Pain Scale) wurden die FMS-Patientinnen nach Schmerzgrad in verschiedene Gruppen eingeteilt. In diesen Gruppen erfolgte dann eine Beurteilung hinsichtlich der folgenden Outcome-Parameter: Krankheitsauswirkungen, Kinesiophobie, schmerzbedingte Probleme und Lebensqualität.

Ergebnisse

Von den FMS-Patientinnen wurden 30 der Gruppe mit gering beeinträchtigenden Schmerzen, 13 der Gruppe mit mäßig beeinträchtigenden Schmerzen und 50 der Gruppe mit stark beeinträchtigenden Schmerzen zugeteilt. Es fanden sich signifikante Unterschiede zwischendiesen drei Gruppen hinsichtlich der Krankheitsauswirkungen (p<0,001), Kinesiophobie (p<0,001), schmerzbedingten Probleme (p=0,017), der physische Komponente der Lebensqualität (p=0,007) und der psychischen Komponente der Lebensqualität (p<0,001). Der Grad der Krankheitsauswirkungen, Kinesiophobie und schmerzbedingten Probleme war in der Gruppe mit stark beeinträchtigenden Schmerzen höher als in der Gruppe mit gering beeinträchtigenden Schmerzen oder mäßig beeinträchtigenden Schmerzen. Der Score für die physische und psychische Komponente der Lebensqualitäts-Messung war in der Gruppe mit stark beeinträchtigenden Schmerzen geringer als in der Gruppe mit gering beeinträchtigenden Schmerzen.

Schlussfolgerung

Menschen, die an FMS mit unterschiedlichen Schmerzgraden leiden, unterscheiden sich hinsichtlich der Krankheitsauswirkungen, des Ausmaßes der Kinesiophobie, der schmerzbedingten Probleme und der Lebensqualität. Die Differenzierung desSchmerzgrades könnte für den Evaluierungsprozess und die spezielle Therapieplanung bedeutsam sein.

Keywords

fibromyalgia - pain - pain intensity - Pain-assessment

Schlüsselwörter

Fibromyalgie - Schmerz - Schmerzassessment - Schmerzen am Bewegungsapparat

Publication History

Received: 27 January 2025

Accepted after revision: 23 June 2025

Article published online:
11 August 2025

• References

• 1 Siracusa R, Paola RD, Cuzzocrea S. et al. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 2021; 22: 3891
• 2 Treede RD, Rief W, Barke A. et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160: 19-27
• 3 Love-Jones SJ. Pain as a subjective, multidimensional experience. Pain: A Rev Guide 2019; 141-144
• 4 Fillingim RB, Loeser JD, Baron R. et al. Assessment of chronic pain: domains, methods, and mechanisms. J Pain 2016; 17: T10-T20
• 5 Von Korff M, DeBar LL, Krebs EE. et al. Graded chronic pain scale revised: mild, bothersome, and high impact chronic pain. Pain 2020; 161: 651
• 6 Ge L, Pereira MJ, Yap CW. et al. Chronic low back pain and its impact on physical function, mental health, and health-related quality of life: a cross-sectional study in Singapore. Sci Rep 2022; 12: 20040
• 7 Leme MD, Yuan SLK, Magalhães MO. et al. Pain and quality of life in knee osteoarthritis, chronic low back pain and fibromyalgia: a comparative cross-sectional study. Reumatismo 2019; 71: 68-74
• 8 Mun CJ, Davis MC, Campbell CM. et al. Linking nonrestorative sleep and activity interference through pain catastrophizing and pain severity: an intraday process model among individuals with fibromyalgia. J Pain 2020; 21: 546-556
• 9 Keefe FJ, Brown GK, Wallston KA. et al. Coping with rheumatoid arthritis pain: catastrophizing as a maladaptive strategy. Pain 1989; 37: 51-56
• 10 Spinhoven P, Ter Kuile MM, Linssen AC. et al. Pain coping strategies in a Dutch population of chronic low back pain patients. Pain 1989; 37: 77-83
• 11 Tagliaferri SD, Miller CT, Owen PJ. et al. Domains of chronic low back pain and assessing treatment effectiveness: a clinical perspective. Pain Pract 2020; 20: 211-225
• 12 George SZ, Bolognesi MP, Bhavsar NA. et al. Chronic pain prevalence and factors associated with high impact chronic pain following total joint arthroplasty: an observational study. J Pain 2022; 23: 450-458
• 13 Booker SQ, Sibille KT, Terry EL. et al. Psychological predictors of perceived age and chronic pain impact in individuals with and without knee osteoarthritis. Clin J Pain 2020; 36: 569
• 14 Wolfe F, Clauw DJ, Fitzcharles MA. et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum WB Saunders. 2016. 46. 319-329
• 15 First MB. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). Biometrics Research. 2002
• 16 Spitzer RL, Kroenke K, Williams JB. et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097
• 17 Von Korff M, Dworkin SF, Le Resche L. Graded chronic pain status: an epidemiologic evaluation. Pain 1990; 40: 279-291
• 18 Özden F, Özkeskin M, Bakırhan S. et al. The reliability and validity of the Turkish version of the graded chronic pain scale in patients with chronic low back pain. Eur Spine J 2021; 30: 2955-2961
• 19 Burckhardt CS, Clark SA, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991; 18: 728-733
• 20 Bennett RM, Friend R, Jones KD. et al. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11: 1-14
• 21 Ediz L, Hiz O, Toprak M. et al. The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire. Clin Rheumatol 2011; 30: 339-346
• 22 Vlaeyen JW, Kole-Snijders AM, Boeren RG. et al. Fear of movement/(re) injury in chronic low back pain and its relation to behavioral performance. Pain 1995; 62: 363-372
• 23 Yilmaz O, Yakut Y, Uygur F. et al. Turkish version of the Tampa Scale for kinesiophobia and its test-retest reliability. Turk J Physiother Rehabil 2011; 22: 44-49
• 24 Amtmann D, Bamer AM, Liljenquist KS. et al. The concerns about pain (CAP) scale: a patient-reported outcome measure of pain catastrophizing. J Pain 2020; 21: 1198-1211
• 25 Saracoglu I, Aksoy CC, Akkurt LL. et al. (2023) Turkish Version of the Concerns About Pain Scale: Reliability and Validity in Patients with Chronic Low Back Pain. Arch Health Sci Res 2023;
• 26 Ware JE, Snow KK, Kosinski M. et al. SF-36 health survey. Manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993
• 27 Ware JE, Keller SD, Kosinski M. SF-12: How to score the SF-12 physical and mental health summary scales. 2^nd ed. Boston: Health Institute, New England Medical Center; 1995
• 28 Globe DR, Levin S, Chang TS. et al. Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmol 2002; 109: 1793-1798
• 29 Soylu C, Kütük B. Reliability and validity of the Turkish version of SF-12 Health Survey. Turk J Psychiatr 2022; 33: 108-117
• 30 Faul F, Erdfelder E, Lang AG. et al. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191
• 31 Herman PM, Broten N, Lavelle TA. et al. Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples. Spine J 2019; 19: 1369-1377
• 32 Pitcher MH, Von Korff M, Bushnell MC. et al. Prevalence and profile of high-impact chronic pain in the United States. J Pain 2019; 20: 146-160
• 33 Silverman S, Sadosky A, Evans C. et al. Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord 2010; 11: 1-9
• 34 Mease PJ, Arnold LM, Crofford LJ. et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Care Res: Off J Am Coll Rheumatol 2008; 59: 952-960
• 35 Moore AR, Straube S, Paine J. et al. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010; 149: 360-364
• 36 Angarita-Osorio N, Pérez-Aranda A, Feliu-Soler A. et al. Patients with fibromyalgia reporting severe pain but low impact of the syndrome: clinical and pain-related cognitive features. Pain Pract 2020; 20: 255-261
• 37 Luque-Suarez A, Martinez-Calderon J, Falla D. Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain: a systematic review. Br J Sports Med 2018; 53: 554-559
• 38 Turk DC, Robinson JP, Burwinkle T. Prevalence of fear of pain and activity in patients with fibromyalgia syndrome. J Pain 2004; 5: 483-490
• 39 Kocyıgıt BF, Akaltun MS. Kinesiophobia levels in fibromyalgia syndrome and the relationship between pain, disease activity, depression. Archives Rheumatol 2020; 35: 214
• 40 Russek L, Gardner S, Maguire K. et al. A cross-sectional survey assessing sources of movement-related fear among people with fibromyalgia syndrome. Clin Rheumatol 2015; 34: 1109-1119
• 41 Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9: 745-758
• 42 Edwards RR, Bingham CO, Bathon J. et al. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Care Res: Off J Am Coll Rheumatol 2006; 55: 325-332
• 43 Şentürk İA, Şentürk E, Üstün I. et al. High-impact chronic pain: evaluation of risk factors and predictors. Korean J Pain 2023; 36: 84-97
• 44 Post M. Definitions of quality of life: what has happened and how to move on. Top Spinal Cord Inj Rehabil 2014; 20: 167-180
• 45 Lorena SBD, Pimentel EADS, Fernandes VM. et al. Evaluation of pain and quality of life of fibromyalgia patients. Rev Dor 2016; 17: 8-11
• 46 Offenbaecher M, Kohls N, Ewert T. et al. Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients. Rheumatol Int 2021; 41: 1995-2006
• 47 Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008; 6: 1-8
• 48 Moreno-Sánchez PA, Arroyo-Fernández R, Bravo-Esteban E. et al. Assessing the relevance of mental health factors in fibromyalgia severity: a data-driven case study using explainable AI. Int J Med Inf 2024; 181: 105280
• 49 Dixon D, Pollard B, Johnston M. What does the chronic pain grade questionnaire measure?. Pain 2007; 130: 249-253
• 50 Galvez-Sánchez CM, Montoro CI, Duschek S. et al. Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia. J Affect Disord 2020; 265: 486-495